Biochemical and virological outcome of patients with chronic hepatitis C treated with interferon alfa-2b for 6 or 12 months: A 4-year follow-up of 211 patients
Data up to Jan 2025
Total Citations Per Year
Abstract
References (33)
Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
1981 • 3,549 citations
Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa
1989 • 1,658 citations
Significance of serum hepatitis C virus RNA levels in chronic hepatitis C
1993 • 822 citations
Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay
1993 • 703 citations
Detection of hepatitis C virus by polymerase chain reaction and response to interferon-α therapy: Relationship to genotypes of hepatitis C virus
1992 • 689 citations
Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration
1996 • 675 citations
Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis
1991 • 542 citations
Epidemiology of Hepatitis C in the West
1995 • 506 citations
Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C
1995 • 474 citations
Factors predictive of response to interferon-α therapy in hepatitis C virus infection
1994 • 444 citations
Incidence of hepatocellular carcinoma in chronic hepatitis B and C: A prospective study of 251 patients
1995 • 421 citations
Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy
1993 • 381 citations
Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C
1995 • 264 citations
Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C
1994 • 234 citations
Therapy of Hepatitis C
1995 • 189 citations
Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C
1995 • 188 citations
Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis
1994 • 166 citations
Degree of diversity of hepatitis C virus quasispecies and progression of liver disease
1994 • 165 citations
Influence of Viral Quasispecies on Effectiveness of Interferon Therapy in Chronic Hepatitis C Patients
1994 • 145 citations
Interferon-α for chronic hepatitis C: An analysis of pretreatment clinical predictors of response
1994 • 142 citations
Prediction of response to interferon treatment of chronic hepatitis C
1994 • 130 citations
Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment
1995 • 105 citations
Hepatic Hepatitis C Virus RNA as a Predictor of a Long-Term Response to Interferon-α Therapy
1995 • 96 citations
Interferon-α in acute posttransfusion hepatitis C:. A randomized, controlled trial
1992 • 94 citations
Factors predictive of the response to interferon in patients with chronic hepatitis C
1994 • 91 citations
Treatment of chronic hepatitis C with recombinant human interferon-α2a: Results of a randomized controlled clinical trial
1994 • 73 citations
Virological and biochemical long-term follow-up of patients with chronic hepatitis c treated with interferon
1994 • 64 citations
[Therapy of hepatitis].
1953 • 46 citations
Interferon-α Treatment in Patients with Chronic Hepatitis C
1995 • 36 citations
Improved sustained response following treatment of chronic hepatitis C by gradual reduction in the interferon dose
1996 • 32 citations
THERAPY OF CHRONIC VIRAL HEPATITIS
1996 • 30 citations
Hepatitis C virus RNA in serum of blood donors with or without elevated transaminase levels
1993 • 27 citations
Serum HCV RNA titer at the end of interferon therapy predicts the long-term outcome of treatment
1995 • 12 citations
Cited By (0)
No citing papers found in database